Teladoc posts $1B loss in 2024 as BetterHelp lags
The direct-to-consumer mental health segment’s adjusted earnings before interest, taxes, depreciation and amortization was down 43% last year from 2023.
Federal Medicaid cuts could shift $44.3B in costs to expansion states
The 41 states that expanded Medicaid could be asked to spend 25% more to cover care costs if planned cuts are approved by Congress. Some states may cut the expansion program instead.
Trump doubles down on price transparency in new executive order
President Donald Trump called upon three federal agencies to enforce a 2019 order requiring hospitals to post prices for services.
Centene expands board with former Prudential finance chief
The appointment of Kenneth Tanji brings the number of directors on Centene’s board to 12.
House Republicans pass budget blueprint that could spell Medicaid cuts
Although the budget resolution does not mention Medicaid specifically, lawmakers would be hard pressed to find enough cuts to meet an $880 billion target without touching federal healthcare programs.
Medicare Advantage growth slows as UnitedHealthcare nabs members, Humana sheds lives
The CMS released highly anticipated MA enrollment data on Tuesday that showed UnitedHealth further tightening its grip on the privatized Medicare market.
Lawmakers call for updated VA Oracle EHR cost estimate
Cost projections for the embattled medical record modernization project range from the VA’s earlier estimate of around $16 billion to an independent evaluation of nearly $50 billion, according to the Government Accountability Office.
Insurers closed out 2024 on shaky footing
Operating income fell for all but two insurance divisions operated by major payers in the fourth quarter. And 2025 may be no better, after many major payers released outlooks suggesting medical costs will continue climbing this year.
Physicians say prior authorization stands in the way of medically necessary care
Physicians surveyed by the American Medical Association say prior authorization can cause care delays or force patients to abandon treatment. Denials could also increase as insurers adopt AI to review claims.
‘Fear and uncertainty’: Biotech investors warn of impact from NIH research cuts
The Trump administration’s plans to reduce NIH grant funding could have long-term consequences for the U.S. drug industry, investors said.